Skip to content
10-K

Annual Report

NIKA PHARMACEUTICALS, INC NIKA

0001826466-26-000026

← back to feed
Filed
Mar 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 1.05B sh
Shares Diluted FY 2025 · Dec 31, 2025 1.05B sh
Shares Diluted FY 2025 · Dec 31, 2024 1.02B sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$79.65K
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$154.93K
Short Term Debt FY 2025 · Dec 31, 2025 $318.62K
Short Term Debt FY 2025 · Dec 31, 2024 $239.16K
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.89K
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.08K
Stockholders Equity FY 2025 · Dec 31, 2025 −$297.63K
Stockholders Equity FY 2025 · Dec 31, 2024 −$221.23K
Stockholders Equity FY 2025 · Dec 31, 2023 −$82.15K
Current Liabilities FY 2025 · Dec 31, 2025 $318.62K
Current Liabilities FY 2025 · Dec 31, 2024 $239.16K
Total Liabilities FY 2025 · Dec 31, 2025 $318.62K
Total Liabilities FY 2025 · Dec 31, 2024 $239.16K
Current Assets FY 2025 · Dec 31, 2025 $21K
Current Assets FY 2025 · Dec 31, 2024 $17.93K
Total Assets FY 2025 · Dec 31, 2025 $21K
Total Assets FY 2025 · Dec 31, 2024 $17.93K
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $53.03K
Sga Expense FY 2025 · Dec 31, 2024 $35.17K
Net Income FY 2025 · Dec 31, 2025 −$76.4K
Net Income FY 2025 · Dec 31, 2024 −$95.79K
Operating Income FY 2025 · Dec 31, 2025 −$76.4K
Operating Income FY 2025 · Dec 31, 2024 −$95.79K